Medicare Enrolled
Dr. Timothy Lesser, MD
Urology Physician · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lesser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lesser?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lesser
Dr. Timothy Lesser is an urology physician in Torrance, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lesser performed 7,388 Medicare services across 3,609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lesser received a total of $14,318 from 68 pharmaceutical and/or device companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lesser is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in CA
$14,318 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,388
Medicare services
Top 14% in CA for urology physician
3,609
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~389 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 1,260 | $65 | $99 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,117 | $2 | $9 |
| BCG treatment for bladder cancer | 859 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
735 | $99 | $600 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
733 | $9 | $60 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
534 | $51 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $69 | $440 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
276 | $92 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
204 | $125 | $780 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
187 | $202 | $1,230 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 161 | $135 | $720 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
133 | $40 | $240 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
87 | $107 | $605 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
86 | $70 | $430 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
84 | $29 | $180 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
84 | $40 | $270 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
80 | $12 | $80 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
72 | $88 | $539 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
45 | $54 | $310 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
43 | $51 | $170 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
39 | $29 | $380 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
30 | $47 | $440 |
| Injection, garamycin, gentamicin, up to 80 mg | 27 | $2 | $12 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $21 | $120 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
25 | $33 | $280 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $109 | $580 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
22 | $8 | $33 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
22 | $10 | $70 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
21 | $20 | $400 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $126 | $730 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
18 | $182 | $1,180 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $71 | $540 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
15 | $90 | $525 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
15 | $126 | $216 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,318
Total received (2018-2024)
Avg $2,045/year across 7 years
Top 15% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
450
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,688 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$630 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,711
2023
$2,414
2022
$2,295
2021
$1,972
2020
$653
2019
$3,457
2018
$1,816
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$277
Sumitomo Pharma America, Inc.
$214
Bayer Healthcare Pharmaceuticals Inc.
$147
Astellas Pharma US Inc
$146
PROCEPT BioRobotics Corporation
$143
Axonics, Inc.
$132
BIOTISSUE HOLDINGS INC.
$108
UROGEN PHARMA, INC.
$108
Myriad Genetic Laboratories, Inc.
$101
Laborie Medical Technologies Corp.
$53
Janssen Biotech, Inc.
$51
Merck Sharp & Dohme LLC
$45
PFIZER INC.
$44
Dendreon Pharmaceuticals LLC
$35
BLUEWIND MEDICAL
$29
Telix Pharmaceuticals
$22
Ethicon US, LLC
$21
PROGENICS PHARMACEUTICALS, INC.
$19
ACCORD HEALTHCARE, INC.
$17
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$3,140
Astellas Pharma US Inc
$1,310
SN Holdings, LLC
$1,150
ABBVIE INC.
$784
Dendreon Pharmaceuticals LLC
$678
Myriad Genetic Laboratories, Inc.
$596
Axonics, Inc.
$362
Sumitomo Pharma America, Inc.
$355
Janssen Biotech, Inc.
$324
PROCEPT BioRobotics Corporation
$282
Bayer Healthcare Pharmaceuticals Inc.
$278
PFIZER INC.
$240
Endo Pharmaceuticals Inc.
$219
BIOTISSUE HOLDINGS, INC.
$209
TISSUETECH, INC.
$209
Smith+Nephew, Inc.
$202
Boston Scientific Corporation
$193
Merck Sharp & Dohme LLC
$173
Teleflex LLC
$172
Myovant Sciences Inc.
$170
Medtronic, Inc.
$167
Blue Earth Diagnostics Limited
$164
Laborie Medical Technologies Corp.
$160
Telix Pharmaceuticals
$154
BioTissue Holdings, Inc.
$147
Otsuka America Pharmaceutical, Inc.
$143
Acerus Pharmaceuticals Corporation
$134
AbbVie, Inc.
$112
Progenics Pharmaceuticals, Inc.
$108
BIOTISSUE HOLDINGS INC.
$108
UROGEN PHARMA, INC.
$108
Bard Access Systems, Inc.
$100
TOLMAR Pharmaceuticals, Inc.
$95
Bayer HealthCare Pharmaceuticals Inc.
$87
Coloplast Corp
$86
Allergan Inc.
$80
Osiris Therapeutics Inc.
$78
UROVANT SCIENCES INC
$72
Accord Healthcare, Inc.
$70
Avadel Specialty Pharmaceuticals, LLC
$67
C. R. Bard, Inc. & Subsidiaries
$60
Photocure Inc
$58
Allergan, Inc.
$57
Amgen Inc.
$56
UroGen Pharma, Inc.
$56
Stryker Corporation
$56
Metuchen Pharmaceuticals
$55
Ethicon US, LLC
$51
Aytu BioScience, Inc
$48
180 Medical, Inc.
$47
Antares Pharma, Inc.
$46
Merck Sharp & Dohme Corporation
$43
Amniox Medical, Inc.
$41
BAXTER HEALTHCARE
$41
Agiliti Surgical, Inc.
$39
ACCORD HEALTHCARE, INC.
$30
BLUEWIND MEDICAL
$29
Alnylam Pharmaceuticals Inc.
$27
Palette Life Sciences, Inc.
$23
Travere Therapeutics, Inc.
$22
CONMED Corporation
$22
AngioDynamics, Inc.
$22
Cook Incorporated
$21
PROGENICS PHARMACEUTICALS, INC.
$19
Duchesnay USA Incorporated
$19
AKRIMAX PHARMACEUTICALS, LLC
$16
Ferring Pharmaceuticals Inc.
$15
Siemens Medical Solutions USA, Inc.
$11
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AIRSEAL · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CAPIO · CLARIX · COOK MEDICAL WIRE GUIDES · CryoCare CS · Cysview · ELIGARD · ERLEADA · EVICEL Fibrin Sealant (Human) · Echelon; Endopath · Eclipse · Erleada · FIRMAGON · FLOSEAL · FLUID MANAGEMENT SYSTEM · GELFOAM · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL BPH · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PL PRIME · ILLUCCIX · INLAY · INTERSTIM · IRIS · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · NEOX · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · Osphena · Otrexup · PREMARIN · PROGEL · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · SPEEDICATH · STRAVIX · SUTENT · Solyx SIS System · Stendra · Stravix · Surgicel Powder · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · Varian CRYOCARE TOUCH System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
352
Per 100K population
3.6
County median income
$87,760
Nearest hospital
PROVIDENCE LITTLE COMPANY OF MARY MED CTR TORRANCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lesser is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lesser experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Lesser performed 1,260 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lesser receive payments from pharmaceutical companies?
Yes. Dr. Lesser received a total of $14,318 from 68 companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lesser's costs compare to other urology physicians in Torrance?
Dr. Lesser's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lesser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Torrance
Browse urology physicians in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
SN Holdings, LLC Payments to Doctors
See all physicians who received payments from SN Holdings, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology